Pangenomic Health Inc.
NARA
CNSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.48% | -783.23% | 84.56% | -71.97% | -48.60% |
| Total Depreciation and Amortization | 0.00% | -93.33% | -95.65% | -95.65% | -95.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 387.61% | 1,824.26% | -99.89% | 204.17% | 121.45% |
| Change in Net Operating Assets | -74.59% | -281.08% | 51.47% | 13.10% | 321.38% |
| Cash from Operations | -618.40% | -9,523.89% | -164.83% | -359.48% | 91.55% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | 298.94% | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -447.06% | -- | -2,858.82% | -- | -- |
| Cash from Financing | 9,991.67% | -- | 256.50% | -- | -99.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -55.50% | 386.73% | 126.92% | -93.10% | -- |